Compared to healthy individuals, the expression of pd-1 and pd-l1 in peripheral blood mononuclear cells (PBMCs) was significantly reduced in RRMS patients, suggesting the breakdown of immunological tolerance in MS [133, 134]. Here, PDCD1 is linked to myeloid sarcoma.